Filippos'iants S T, Malkova I V, Gol'dberg L E
Antibiot Khimioter. 1989 Jul;34(7):523-6.
Pharmacokinetic parameters of eremomycin (Institute of New Antibiotics, the USSR Academy of Medical Sciences), teichoplanin (Lepetit) and vancomycin (Eli Lilly) were compared after their intravenous administration to rats in the same dose of 50 mg/kg. It was shown that the area under the concentration time curve of eremomycin was 2 times smaller than that of teichoplanin and 6 times larger than that of vancomycin. The mean retention time of eremomycin was close to that of teichoplanin and 1.6 times higher than that of vancomycin. Bioavailability of eremomycin and teichoplanin after their extravascular administration was the same and amounted to 94 per cent. Antibacterial activity of eremomycin against methicillin resistant strains of staphylococci was 4 times higher than that of teichoplanin and vancomycin.
在以50mg/kg的相同剂量对大鼠静脉注射后,比较了埃瑞霉素(苏联医学科学院新抗生素研究所)、替考拉宁( Lepetit公司)和万古霉素(礼来公司)的药代动力学参数。结果表明,埃瑞霉素浓度-时间曲线下面积比替考拉宁小2倍,比万古霉素大6倍。埃瑞霉素的平均保留时间与替考拉宁相近,比万古霉素高1.6倍。埃瑞霉素和替考拉宁血管外给药后的生物利用度相同,均为94%。埃瑞霉素对耐甲氧西林葡萄球菌菌株的抗菌活性比替考拉宁和万古霉素高4倍。